Back
Exelixis Vs. ADMA Biologics Industry Stock Comparison
Buy
72
EXEL
Exelixis
Last Price:
$33.29
Seasonality Move:
4.86%
Buy
60
ADMA
ADMA Biologics
Last Price:
$17.44
Seasonality Move:
2.93%
Buy
60
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
-
The current ADMA Biologics [ADMA] share price is $17.40. The Score for ADMA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ADMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXEL Stock Price Chart
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $17.40Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight selling pressure.
EXEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 40.46 | Sell |
Chaikin Money Flow: | -2514109 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.32 - 36.04) | Sell |
Bollinger Bands (100): | (25.29 - 33.97) | Buy |
ADMA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 36.96 | Sell |
Chaikin Money Flow: | -1885228 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.47 - 20.95) | Sell |
Bollinger Bands (100): | (15.72 - 20.54) | Sell |
EXEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.63 | Sell |
20-day SMA: | 35.34 | Sell |
50-day SMA: | 33.24 | Buy |
200-day SMA: | 26.02 | Buy |
8-day EMA: | 34.37 | Sell |
20-day EMA: | 34.73 | Sell |
50-day EMA: | 33.15 | Buy |
200-day EMA: | 27.48 | Buy |
ADMA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.44 | Sell |
20-day SMA: | 19.54 | Sell |
50-day SMA: | 18.85 | Sell |
200-day SMA: | 13.53 | Buy |
8-day EMA: | 18.31 | Sell |
20-day EMA: | 19.03 | Sell |
50-day EMA: | 18.96 | Sell |
200-day EMA: | 14.51 | Buy |
Exelixis Earnings Growth & EXEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $0.05 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.17 per share.
Exelixis Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ADMA Biologics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |